Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.
Return to search results

GEO Series: GSE153925

Title: Comprehensive expression profile reveals dynamic changes in Xenopus gene expression depending on the duration of activin A treatment.

Summary

In amphibian embryo, the animal cap explants treated with activin A, which is a member of TGF-β family protein, have a potent of Spemann-Mangold organizer-like activities, leading the induction of mesendodermal tissue. We report the temporal RNA expression profile of the mesendodermal cell lineage induced by activin A to Xenopus animal cap explants, which have multipotency. Depending on the duration of activin A treatment to animal cap, dynamic changes of gene expressions were observed. Overview of samples: As the sample for RNA-seq, animal cap explants from Xenopus blastulas (stage 8.5) were cultured in activin A solution (50 ng/mL) for 1, 3, 6, and 9 hours (Post 1h_, Post_3h_, Post 6h_, and Post 9h_activin), and activin A-untreated control (Pre_activin) were also prepared. Results: We first tested the principal component analysis (PCA) for gene expression at individual time points, and found that three biological replicates of individual time points made clusters together. To compare the gene expression between activin A-treated and -untreated samples, we then visualized gene expression of 45099 annotated genes. The heat map visualization showed the distinct clusters between individual time points, and also revealed the significant changes of gene expression levels depending on the duration of activin A treatment. Analysis for differentially expressed genes (DEGs) (fold change >2 with false discovery rate at p<0.05) showed upregulated and downregulated genes by activin A treatment, in comparison with Pre_activin sample. Gene number of upregulated (up), downregulated (down) genes, and treatment time of activin A were described as follows; 2573 (up), 111 (down), 1h; 4149 (up), 1901 (down), 3h; 6323 (up), 4704 (down), 6h; 8858 (up), 6008 (down), 9h. From the data set of analysis for enriched Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway, we assessed the molecular functions and signaling pathway of upregulated DEGs at each time point of activin A treatment, in comparison with Pre_activin sample. Conclusions: Regarding the temporal expression of organizer genes such as goosecoid (gsc), orthodenticle homeobox 2 (otx2) and chordin (chrd), our transcriptome data using mesendodermal cells derived from animal cap explants was correlated with previous findings using mesendodermal region from Xenopus embryos. Our transcriptome data from animal cap assay may cover the transition of gene expression from undifferentiated cells to mesendodermal tissue during the normal early development.


Contributors: Jun-Dal Kim, Yumeko Kobayashi, Makoto Asashima, Akiyoshi Fukamizu

Experiment Type: Time-course RNA expression data from Xenopus animal cap treated with activin A. mRNA profiles of animal caps were generated by RNA sequencing using the NextSeq 500 (Illumina).

Experiment Reagents: Durabolin.

Phenotypes:
Xla Wt + Activin + animal cap explant + animal cap NF10.25 6h (RNA-Seq (RNA))

Article: XB-ART-58287, PubMed

Source: NCBI GEO, Xenbase Download

Samples: (DEG = Differentially Expressed Genes; GSM = GEO Sample Number)
Sample View GSMs Assay Type
animal cap - NF8 GSM4658472  GSM4658473  GSM4658474  RNA-Seq
Background: Xla.Inbred
Conditions:
Tissue Assay Stages ChIP Antibody
animal cap NF stage 8  
   animal cap - Activin + animal cap explant - NF10.25 DEG GSM4658481  GSM4658482  GSM4658483  RNA-Seq
Background: Xla.Inbred
Manipulations:
Manipulation Type Reagent Target Gene Stage Treatment Area
chemical Durabolin NF stage 1 animal cap
explant   NF stage 8 animal cap
Conditions:
Tissue Assay Stages ChIP Antibody
animal cap NF stage 10.25  
   animal cap - Activin + animal cap explant - NF12.5 DEG GSM4658484  GSM4658485  GSM4658486  RNA-Seq
Background: Xla.Inbred
Manipulations:
Manipulation Type Reagent Target Gene Stage Treatment Area
chemical Durabolin NF stage 1 animal cap
explant   NF stage 8 animal cap
Conditions:
Tissue Assay Stages ChIP Antibody
animal cap NF stage 12.5  
   animal cap - Activin + animal cap explant - NF8 DEG GSM4658475  GSM4658476  GSM4658477  RNA-Seq
Background: Xla.Inbred
Manipulations:
Manipulation Type Reagent Target Gene Stage Treatment Area
chemical Durabolin NF stage 1 animal cap
explant   NF stage 8 animal cap
Conditions:
Tissue Assay Stages ChIP Antibody
animal cap NF stage 8  
   animal cap - Activin + animal cap explant - NF9 DEG GSM4658478  GSM4658479  GSM4658480  RNA-Seq
Background: Xla.Inbred
Manipulations:
Manipulation Type Reagent Target Gene Stage Treatment Area
chemical Durabolin NF stage 1 animal cap
explant   NF stage 8 animal cap
Conditions:
Tissue Assay Stages ChIP Antibody
animal cap NF stage 9  
Select All DEG      Select All 
Xtr   
Xla 

Return to search results